The U.K.’s National Institute for Health and Care Excellence (NICE) published on Tuesday draft guidance recommending Autolus Therapeutics plc’s (NASDAQ:AUTL) Aucatzyl (obecabtagene autoleucel, or obe-cel) for use in the National Health Service (NHS) for adult patients (≥26 years) with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL).
• AUTL stock is showing exceptional strength. Get the market research here.
Acute lymphoblastic leukemia is a cancer of the blood and bone marrow, where the body produces too many immature lymphocytes, a type of white blood cell.
Aucatzyl will be available through routine commissioning by the NHS. Autolus intends to launch Aucatzyl in England and Wales imminently and pursue patient access through the Scottish Medical Consortium.
Also Read: FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorisation for Aucatzyl in April 2025. The MHRA authorization of Aucatzyl was based on the results of the FELIX study in adult patients with relapsed or refractory B-cell acute lymphoblastic leukaemia.
Obecabtagene autoleucel is an autologous CD19 CAR T cell therapy with a proprietary CD19 CAR.
How To Buy AUTL Stock
By now, you're likely curious about how to participate in the market for Autolus Therapeutics — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
In the case of Autolus Therapeutics, which traded at $1.38 some time Tuesday, $100 would buy you 72.46 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
AUTL Price Action: Autolus stock is up 10.48% at $1.37 at publication on Tuesday.
Read Next:
Photo: Tom Robertson via Shutterstock
